FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for TORISEL (temsirolimus) from Wyeth Pharmaceuticals (a Pfizer subsidiary).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

SUPPL AP for TORISEL (TEMSIROLIMUS)